Research / ULBI / Fundamental state Inspectable configuration
State dimensions Filing 0001437749-24-034608 General Corporate
Debt relative to revenue 27th Own-history percentile · N=11
Evidence method Level · gp.fundamentals.debt_to_revenue
22.10% · OPTIONAL · VALID
Capex intensity 82th Own-history percentile · N=11
Evidence method Level · gp.fundamentals.capex_revenue_ratio
1.66% · OPTIONAL · VALID
Operating cash generation 91th Own-history percentile · N=11
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
13.30% · OPTIONAL · VALID
Revenue growth RAW Current state valid · history insufficient
Evidence method Yoy · gp.fundamentals.revenue
-9.61% · CORE · NOT_ENOUGH_HISTORY
Inventory pressure 91th Own-history percentile · N=11
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
123.25% · OPTIONAL · VALID
Gross margin 45th Own-history percentile · N=11
Evidence method Level · gp.fundamentals.gross_margin
24.32% · CORE · VALID
Operating margin 45th Own-history percentile · N=11
Evidence method Level · gp.fundamentals.operating_margin
1.43% · CORE · VALID
R&D intensity 73th Own-history percentile · N=11
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
5.89% · OPTIONAL · VALID
SBC intensity 60th Own-history percentile · N=10
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.48% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 19 states Self-history eligible
Dec 31, 2021 0/8 normalized Level 3 Mar 31, 2022 0/8 normalized Level 3 Jun 30, 2022 0/7 normalized Level 3 Sep 30, 2022 0/8 normalized Level 3 Dec 31, 2022 0/9 normalized Level 3 Mar 31, 2023 0/9 normalized Level 3 Jun 30, 2023 0/9 normalized Level 3 Sep 30, 2023 0/9 normalized Level 3 Dec 31, 2023 7/9 normalized Level 3 Mar 31, 2024 8/9 normalized Level 3 Jun 30, 2024 8/9 normalized Level 3 Sep 30, 2024 8/9 normalized Level 3 Dec 31, 2024 9/9 normalized Level 3 Mar 31, 2025 9/9 normalized Level 3 Jun 30, 2025 9/9 normalized Level 3 Sep 30, 2025 9/9 normalized Level 3 Dec 31, 2025 9/9 normalized Level 3 Mar 31, 2026 9/9 normalized Level 3 Jun 30, 2026 9/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 27.87%
Current 22.10%
Delta -5.77% Capex Intensity Increased
Previous 0.84%
Current 1.66%
Delta 0.83% Cash Generation Decreased
Previous 20.76%
Current 13.30%
Delta -7.47% Growth Decreased
Previous 0.68%
Current -9.61%
Delta -10.29% Inventory Pressure Increased
Previous 96.30%
Current 123.25%
Delta 26.95% Margin Decreased
Previous 26.90%
Current 24.32%
Delta -2.58% Profitability Decreased
Previous 9.11%
Current 1.43%
Delta -7.68% R And D Intensity Increased
Previous 4.65%
Current 5.89%
Delta 1.24% Sbc Intensity Increased
Previous 0.37%
Current 0.48%
Delta 0.11% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.